Pari Homepage

Results will be updated as you type

News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

Digital illustration of lungs with connected data structures and technical graphics, featuring the eFlow® Technology logo.

Categories

  • PARI News
  • Partner News
  • PARI Publications
  • Publications
  • eFlow Integrated

Posts of category: Publications

Peer-reviewed research, clinical studies, and scientific papers related to eFlow® Technology and inhaled therapies.

Published
August 14, 2019
Category
  • Publications

Making Concentrated Antibody Formulations Accessible for Vibrating-Mesh Nebulization.

Published
May 22, 2019
Category
  • Publications

Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates.

Published
May 15, 2019
Category
  • Publications

A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation.

Published
January 30, 2019
Category
  • Publications

A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis.

Published
November 10, 2017
Category
  • Publications

In vitro characterization of the eFlow closed system nebulizer with glycopyrrolate inhalation solution.

Previous page
of 9
Next page

Back to overview

  1. eFlow Partnering
  2. News & Publications
  3. Categories
Link to PARI at LinkedIn

+49 (0) 8151 279 279
 

Contact

  • Career
  • Press portal
  • Partner with us
  • PARI INT
  • Imprint
  • Data Protection
  • Cookie Consent
  • Accessibility Statement
  • General Terms and conditions

© 2026 PARI GmbH Spezialisten für effektive Inhalation